Výsledky vyhledávání - "Carlos, Camps Herrero"

Akademický článek

Relation of Malnutrition and Nosocomical Infections in Cancer Patients in Hospital: An Observational Study

Autor: Bianca Tabita Muresan, Martín Núñez‐Abad, Ana Artero, Jaime Rios Rios, Alberto Jacobo Cunquero-Tomás, Vega Iranzo, Javier Garrido, Ana Jiménez-Portilla, Carlos Camps Herrero, Carlos J. Sánchez Juan

Publikováno v: Journal of Nutrition and Metabolism, Vol 2022 (2022)

Aim. To investigate the relation between malnutrition and nosocomial infections (NI) in hospitalized cancer patients. Methods. This observational, cross-sectional, noninterventional, descriptive study was conducted in a 500-bed university hospital in

Externí odkaz: https://doaj.org/article/3e5a4a9aa9b149efb3202ec2a489608e

Zobrazit plný text záznamu

Plný text ve formátu HTML

Akademický článek

Update on systemic treatment in early triple negative breast cancer

Autor: Martín Núñez Abad, Silvia Calabuig-Fariñas, Miriam Lobo de Mena, María José Godes Sanz de Bremond, Clara García González, Susana Torres Martínez, José Ángel García-García, Vega Iranzo González-Cruz, Carlos Camps Herrero

Publikováno v: Therapeutic Advances in Medical Oncology, Vol 13 (2021)

Triple negative breast cancer (TNBC) is a heterogeneous disease representing about 15% of all breast cancers. TNBC are usually high-grade histological tumors, and are generally more aggressive and difficult to treat due to the lack of targeted therap

Externí odkaz: https://doaj.org/article/ed8878228d67443994a91fff5ce314e6

Zobrazit plný text záznamu

[Nutritional assessment and intervention in hospitalized cancer patients at risk of or with malnutrition: evaluation of the effect on anthropometric and body composition parameters]

Autor: Bianca Tabita Muresan, Ana Jiménez-Portilla, Ana Artero, Yesica Ruiz Berjaga, María del Mar Llamas Montero, Miriam Lobo de Mena, Carlos Camps Herrero, Carlos Sánchez Juan

Publikováno v: Nutricion hospitalaria. 39(6)

Introduction: malnutrition is a common problem in cancer patients that worsens during hospitalization and is associated with increased morbidity and mortality, and impaired quality of life. Objectives: to describe the effect of implementing a nutriti

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e18c9eadec24f6e1c5afa19feeb609e
https://pubmed.ncbi.nlm.nih.gov/36454010

Zobrazit plný text záznamu

Programmed Death-Ligand 1 (PD-L1) as Immunotherapy Biomarker in Breast Cancer

Autor: Martín Núñez Abad, Silvia Calabuig-Fariñas, Miriam Lobo de Mena, Susana Torres-Martínez, Clara García González, José Ángel García García, Vega Iranzo González-Cruz, Carlos Camps Herrero

Publikováno v: Cancers
r-CIPF. Repositorio Institucional Producción Científica del Centro de Investigación Principe Felipe (CIPF)
instname
Cancers, Vol 14, Iss 307, p 307 (2022)

Simple Summary Breast cancer (BC) is the most common malignant neoplasm in women and one of the leading causes of cancer death in women worldwide. Programmed death-ligand 1 (PD-L1) is becoming an emerging biomarker in BC in recent years. It has been

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c427a13568d5089cfe9090bc94ab6567
https://fundanet.cipf.es/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=3925

Zobrazit plný text záznamu

Clinical and technical insights of tumour mutational burden in non-small cell lung cancer

Autor: Marina Meri-Abad, Andrea Moreno-Manuel, Sandra Gallach García, Silvia Calabuig-Fariñas, Rafael Sirera Pérez, Carlos Camps Herrero, Eloisa Jantus-Lewintre

Publikováno v: Critical Reviews in Oncology/Hematology. 182:103891

Despite the durable responses provided by the introduction of checkpoint inhibitors in advanced Non-Small Cell Lung Cancer (NSCLC) without actionable targets in a subset of patients, a large proportion of them will progress after immunotherapy. Progr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9d7bb39761cba7ff990bd5fd04baf58
https://doi.org/10.1016/j.critrevonc.2022.103891

Zobrazit plný text záznamu

Working towards a consensus on the oncological approach of breakthrough pain: a Delphi survey of Spanish experts

Autor: Jesús García-Foncillas, Pere Gascón, Manuel Constenla, Carlos Camps Herrero, V. Guillem, Alfredo Carrato, Eduardo Díaz-Rubio, Margarita Feyjoo Saus, Antonio Antón Torres, Juan J. Cruz-Hernández

Publikováno v: Journal of Pain Research. 12:2349-2358

Purpose There is a lack of standards for the diagnosis, assessment and management of breakthrough cancer pain (BTcP). La Fundacion ECO (the Foundation for Excellence and Quality in Oncology) commissioned a study to establish a consensus and lay the f

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c8409c43446812ffd61430a1e4568c8a
https://doi.org/10.2147/jpr.s203903

Zobrazit plný text záznamu

Role of RAS mutation status as a prognostic factor for patients with advanced colorectal cancer treated with first-line chemotherapy based on fluoropyrimidines and oxaliplatin, with or without bevavizumab: A retrospective analysis

Autor: Eloisa Jantus‑Lewintre, Carlos Camps Herrero, Elena Evgenyeva, Mireia Gil Raga, Sonia Maciá Escalante, Antonio Llombart Cussac, Javier Garde Noguera

Publikováno v: Molecular and Clinical Oncology. 6:403-408

The role of Kirsten rat sarcoma viral oncogene homolog (KRAS) and neuroblastoma RAS viral oncogene homolog (NRAS) mutations as negative predictors for anti-epidermal growth factor receptor (EGFR) therapies in metastatic colorectal cancer (CRC) has be

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ccf572d94dc08b8b6a3639d403fbfc83
https://doi.org/10.3892/mco.2017.1149

Zobrazit plný text záznamu

Working towards a consensus on the oncological approach of breakthrough pain: a Delphi survey of Spanish experts

Autor: Carlos, Camps Herrero, Antonio, Antón Torres, Juan Jesús, Cruz-Hernández, Alfredo, Carrato, Manuel, Constenla, Eduardo, Díaz-Rubio, Margarita, Feyjoo Saus, Jesus, Garcia-Foncillas, Pere, Gascón, Vicente, Guillem

Publikováno v: Journal of Pain Research

Purpose There is a lack of standards for the diagnosis, assessment and management of breakthrough cancer pain (BTcP). La Fundación ECO (the Foundation for Excellence and Quality in Oncology) commissioned a study to establish a consensus and lay the

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::333e5eab29e1ebf5cc9c4a340d2f24b7
https://pubmed.ncbi.nlm.nih.gov/31534359

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání